🇺🇸 FDA
Patent

US 7790766

Pharmaceutical compositions of short-acting sedative hypnotic agent

granted A61KA61K31/20A61K31/216

Quick answer

US patent 7790766 (Pharmaceutical compositions of short-acting sedative hypnotic agent) held by Theravance, Inc. expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/20, A61K31/216, A61K31/325, A61K9/1075